Manganese Neurotoxicity: a Focus on Glutamate Transporters

Pratap Karki; Eunsook Lee; Michael Aschner

doi:10.1186/2052-4374-25-4

Articles

Page Path: HOME > Ann Occup Environ Med > Volume 25; 2013 > Article

Review Manganese Neurotoxicity: a Focus on Glutamate Transporters: Pratap Karki¹, Eunsook Lee¹, Michael Aschner²; Annals of Occupational and Environmental Medicine 2013;25:4-4.
DOI: https://doi.org/10.1186/2052-4374-25-4
Published online: May 21, 2013

¹Department of Physiology, Meharry Medical College, Nashville, TN, USA

²Department of Pediatrics, Vanderbilt University Medical Center, 2215-B Garland Avenue, 11415 MRB IV, Nashville, TN, 37232-0414, USA

• Received: January 24, 2013 • Accepted: March 1, 2013

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

58 Views
0 Download
55 Web of Science
55 Crossref

prev next

Full Article

Download PDF

Abstract
Review
Mn neurotoxicity
The effect of Mn on astrocytic glutamate transporters
Conclusion
Competing interests
Authors’ contributions
Acknowledgements
References

Abstract

Manganese (Mn) is an essential element that is required in trace amount for normal growth, development as well maintenance of proper function and regulation of numerous cellular and biochemical reactions. Yet, excessive Mn brain accumulation upon chronic exposure to occupational or environmental sources of this metal may lead to a neurodegenerative disorder known as manganism, which shares similar symptoms with idiopathic Parkinson’s disease (PD). In recent years, Mn exposure has gained public health interest for two primary reasons: continuous increased usage of Mn in various industries, and experimental findings on its toxicity, linking it to a number of neurological disorders. Since the first report on manganism nearly two centuries ago, there have been substantial advances in the understanding of mechanisms associated with Mn-induced neurotoxicity. This review will briefly highlight various aspects of Mn neurotoxicity with a focus on the role of astrocytic glutamate transporters in triggering its pathophysiology.
Keywords: Manganese; Neurotoxicity; Astrocytes; Glutamate transporters

Review

Mn is essential but needs to be in the balance

Mn is a ubiquitous element present naturally in the environment, including water and food. In the human body, Mn is found in all tissues where it is required for normal amino acid, lipid, protein and carbohydrate metabolism, and ATP generation. Mn also participates in blood clotting and sugar homeostasis, immune responsiveness, digestion, reproduction, and bone growth [1-3]. It is a critical component of numerous metalloenzymes, including Mn superoxide dismutase, arginase, phosphoenolpyruvate decarboxylase and glutamine synthetase [4-6], to name a few. Despite its requirement in multiple physiological processes, elevated levels of Mn trigger toxicity, particularly within the central nervous system (CNS), causing cognitive, psychiatric and motor abnormalities [7,8]. In humans, Mn deficiency is rare as it is abundant in diets, but in extenuating conditions it may contribute to developmental defects, including malformation of bones, altered macromolecular metabolism, reduced fertility, weakness and enhanced susceptibility to seizures [3,9,10]. Mn deficiency has also been shown to induce skeletal defects and impaired lipid metabolism [11,12].

Sources of human exposure

Mn is naturally abundant in the Earth’s crust (0.1%) and soil (40–900 mg/kg) [13,14]. Mn is found as oxides, carbonates and silicates in minerals. The versatile chemical properties of Mn have expanded its industrial use in glass, ceramics, paint and adhesive industries, as well as in welding. The wide usage of Mn in a range of industries has led to global health concerns. Indeed, occupational exposures to Mn have been documented in multiple industries, including ferroalloy smelting, welding, mining, battery, glass and ceramics [15-19].

The primary source of Mn exposure in the general human population is from diet, which is estimated to contain 0.9-10 mg Mn per day [20]. Rice, grains and nuts are rich sources of Mn with excess of 30 mg/kg, while Mn content in tea is 0.4-1.3 mg/cup. Mn drinking water levels are in the range of 1–100 μg/L [21]. The high Mn content in infant formulas compared to human milk, has recently drawn public attention [22], along with Mn in parenteral nutrition. The latter is considered a risk factor for Mn-induced toxicity since the normal intestinal regulatory mechanisms are bypassed, rendering intravenously delivered Mn 100% bioavailable [23,24]. Mn in fumes, aerosols or suspended particulate matters is deposited in the upper and lower respiratory tract, with subsequent entry into the bloodstream. An Mn-containing gasoline anti-knock additives additive, methylcyclopentadienyl manganese tricarbonyl (MMT), has been introduced in several countries, representing another source of Mn exposure via inhalation [25,26]. Designer drugs, such as methcathinone hydrochloride (ephedrine), where potassium permanganate is used as an oxidant for the synthesis of the illicit drugs [27] has also been shown to cause neurodegenerative sequalae in drug abusers, consistent with PD-like symptomology.

Mn absorption, transport and excretion

Diet represents the major source of Mn in humans. The gastrointestinal tract absorbs 1-5% of ingested Mn; 60-70% of inhaled Mn is exhaled by the lungs [28,29]. The uptake of Mn is tightly regulated and excess Mn is excreted through the bile [30]. Both active transport and passive diffusion mechanisms regulate oral Mn absorption and the process is governed by various factors, including dietary levels of Mn and other minerals as well as age [20,30,31]. Among other metals, iron (Fe) stores are particularly important given the inverse relationship between cellular Fe levels and Mn uptake, as evidenced by increased transport of orally administered Mn in states of Fe deficiency [32,33]. In blood, Mn⁺² is predominantly (>99%) in the 2+ oxidation state and mainly bound to β-globulin and albumin. A small fraction of Mn⁺³ is complexed with transferrin [34,35]. Mn (in the 2+ oxidation state) transport across the blood–brain barrier (BBB) and cell membranes is facilitated by the divalent metal ion transporter 1 (DMT1), N-methyl-d-aspartate (NMDA) receptor channel and Zip8 [36-38], to name a few. Transferrin is the most efficient transport system for Mn in the 3+ oxidation state [39]. Mn is distributed throughout the brain and the highest Mn levels are found in the globus pallidus and other nuclei of the basal ganglia (striatum, substantia nigra) [40,41]. DMT1 and transferrin also regulate Mn uptake both in astrocytes and neurons [42,43]. Generally, the intracellular Mn concentration is higher in tissues rich in mitochondria and pigmentation. The highest Mn levels are noted in bone, liver, pancreas and kidney compared to other tissues [44].

Mn neurotoxicity

Mn in neurological disorders

Chronic inhalation of air-borne Mn particulates represents the major cause of human neurotoxicity, though there is growing number of reports on Mn toxicity resulting from consumption of Mn-adulterated drinking water [45,46]. Occupational exposures represent the predominant source of excessive Mn exposure [47]. Manganism, first described by Couper in 1837 [48] is a clinical disorder characterized by psychological and neurological abnormalities that shares multiple analogous symptoms with idiopathic PD [Reviewed in [49]]. The early symptoms of manganism include hallucinations, psychoses and various behavioral disturbances soon followed by postural instability, dystonia, bradykinesia and rigidity [50]. Despite their resemblance in clinical features, manganism is clinically distinguishable from PD [51]. Mn-induced neurotoxicity affects mainly the globus pallidus as well as the cortex and hypothalamus [52,53], distinct from the striatal changes associated with PD. Excessive CNS Mn levels may contribute in the pathogenesis of PD, causing loss of dopamine in the striatum, death of non-dopaminergic (DAergic) neurons in the globus pallidus, and damage to glutamatergic and GABAergic projections [54,55]. Mn has also been shown to increase fibril formation by α-synuclein along with its expression and aggregation [53,56,57]. While playing a major role in the etiology of PD [58], the precise role of α-synuclein in Mn-induced neurotoxicity has yet to be determined. A role for Mn has also been advanced in the etiology of Huntington’s disease, amyotrophic lateral sclerosis and Alzheimer’s disease [Reviewed in [49]].

Mechanism of Mn Neurotoxicity

Mitochondrial dysfunction

Mitochondria serve as the primary storage site for intracellular Mn where it is taken up by the calcium uniporter [59]. Mn is also an important cofactor for various mitochondrial enzymes and, thus, the elevation in Mn levels in this organelle can directly interfere with oxidative phosphorylation. Mn inhibits the function of F1-ATPase and the formation of complex I of the electron transport chain, thereby interfering with cellular ATP synthesis [60,61].

Oxidative stress

Elevated intra-mitochondrial Mn levels trigger oxidative stress, generating the excessive reactive oxygen species (ROS), causing mitochondrial dysfunction [61,62]. The transition of Mn⁺² to Mn⁺³ increases its pro-oxidant capacity [63]. Mn-induced oxidative stress leads to the opening of mitochondrial transition pore (MTP), resulting in increased solubility to protons, ions and solutes, loss of the mitochondrial inner membrane potential, impairment of oxidative phosphorylation and ATP synthesis and mitochondrial swelling [64,65]. Furthermore, Mn exposure has also been linked to the activation of signaling pathways involved in response to oxidative stress, including nuclear factor kappa B (NF-_kB) and activator protein-1 (AP-1) [66,67].

Apoptosis

Neuronal cell death by apoptosis has been considered to play a major role in neurodegenerative diseases, including PD [68]. Mn has been shown to trigger apoptosis in DAergic neurons in a caspase-3-dependent manner by activation of protein kinase C delta (PKC-δ) [69]. Similarly, Mn has been shown to cause apoptotic cell death in astrocytes by mitochondrial pathways involving cytochrome c release and caspase activation [64,70].

Inflammation

Although the oxidative stress induced by mitochondrial dysfunction is regarded as the major pathological mechanism of Mn neurotoxicity, recent studies also suggest a proinflammatory role for Mn, which involves the activation of glial cells characterized by the release of non-neuronal derived ROS, such as nitric oxide (NO), cytokines, prostaglandins and H₂O₂[71-73]. Mn potentiates the release of several cytokines, including TNF-α, IL-6, IL-1β from the activated glial cells, thereby activating various transcription factors including NF-_kB, AP-1 and kinases including ERK, JNK, AKT, and PKC-α [Reviewed in [74]].

The effect of Mn on astrocytic glutamate transporters

Astrocytes are the site of early dysfunction and damage in Mn neurotoxicity. Astrocytes are the most abundant CNS cells (~50% by volume), and they perform numerous essential functions for normal neuronal activity, such as glutamate uptake, glutamine release, K⁺ and H⁺ buffering and volume regulation [36,75,76]. Astrocytes accumulate up to 50-fold higher Mn concentrations compared to neurons, thus serving as the main homeostatic and storage site for this metal [75,77]. The intracellular concentration of Mn in astrocytes is ~50-75 μM where it is an essential cofactor for the astrocyte-specific enzyme glutamine synthetase, which catalyzes the conversion of glutamate to glutamine [78,79]. The excessive accumulation of Mn in astrocytes mediates neurotoxicity primarily by oxidative stress and impairment of glutamate transporters [80,81]. Mn toxicity has been shown to cause astrocytic alterations in primate models, and exposure of pathophysiologically relevant Mn concentrations in astrocytes in vitro causes time-and concentration-dependent cell swelling secondary to oxidative stress [82,83]. One of the proposed mechanisms of Mn-induced neurotoxicity in astrocytes is alteration in glutamate homeostasis due to impairment of glutamate transporters [84]. Mn has also been shown to downregulate the expression and function of glutamine transporters, resulting in reduced glutamine uptake [85]. The impairment of glutamate/glutamine transporters results in increased extracellular glutamate levels that elicit excitatory neurotoxicity. In support of this mechanism, we and others have shown that estrogen and selective estrogen receptor modulators protect astrocytes from Mn-induced neurotoxicity by upregulating the expression and function of glutamate transporters [86-88]. Moreover, Mn also activates selective cellular signaling pathways that mediate alterations in glutamate-glutamine homeostasis. The decrease in glutamine uptake after the activation of PKC-δ by Mn represents a typical example of the involvement of signaling pathways in Mn-induced neurotoxicity [89].

Although it is widely accepted that Mn impairs the expression and function of the two main glutamate transporters (GLAST and GLT-1), its mechanism of action at the transcriptional levels remains unknown. The increased production of ROS and TNF-α by Mn is thought to be the principal cause that leads to impairment in glutamate transporter function. ROS inhibit astrocyte glutamate uptake, and TNF-α decreases GLAST and GLT-1 protein and mRNA levels [90-92]. Oxidative stress also plays an important role in the regulation of glutamate transporter function since the activity of glutamate transporters is regulated by the redox state of reactive cysteine residues, with a dramatic decrease in activity once the reduced cysteine is oxidized [93]. Furthermore, glutamate uptake by the recombinant glutamate transporters EAAT1, EAAT2 and EAAT3 was found to be inhibited by peroxynitrite and H₂O₂ and restored upon treatment with the reducing agent, dithithreotol, suggesting a role for oxidative stress in the regulation of glutamate transporters activity [94]. TNF-α is a key neuroinflammatory mediator of neurotoxicity and neurodegeneration, and Mn increases the levels of this cytokine [95]. Several studies also corroborate the reduction in the expression and activity of glutamate transporters by TNF-α, highlighting its role as a negative regulator of the transporter [90,92]. NF-_kB and MAPK signaling pathways mediate TNF-α-induced reduction in GLT-1 expression, since the inhibition of these pathways restores the decrease in TNF-α induced GLT-1 expression and function [92].

Conclusion

Chronic excessive exposures to Mn represent a global health concern as growing evidences suggests that Mn accumulation in the brain may be a predisposing factor for several neurodegenerative diseases. Studies over the past several decades have provided invaluable insights into the cause, effects and mechanisms of Mn-induced neurotoxicity. The recent findings on the involvement of glutamate transporters and cellular signaling pathways in Mn-induced neurotoxicity provide not only new insights into the molecular mechanisms of Mn-induced neurotoxicity, but also provide new therapeutic targets in the development of novel drugs to attenuate the symptoms associated with manganism, PD and other related neurodegenerative disorders.

Competing interests

The authors declare that there is no any competing interest.

Authors’ contributions

PK drafted the initial manuscript, EL and MA corrected, edited and finalized it. All the authors read and approve the final version of the manuscript.

Acknowledgements

The studies in our laboratories are supported by NIH grants R01 ES 10563, P30 ES 00267 and SC1 GM089630.

References

Aschner M, Erikson KM, Dorman DC: Crit Rev Toxicol. 2005;25: 1–32. 10.1080/10408440590905920. 15742901.
Erikson KM, Thompson K, Aschner J, Aschner M: Pharmacol Ther. 2007;25: 369–377. 10.1016/j.pharmthera.2006.09.002. 17084903.
Aschner JL, Aschner M: Mol Aspects Med. 2005;25: 353–362. 10.1016/j.mam.2005.07.003. 16099026.
Baly DL: J Nutr. 1985;25: 327.
Bentle LA, Lardy HA: J Biol Chem. 1976;25: 2916–2921. 1270433.
Stallings WC, Metzger AL, Pattridge KA, Fee JA, Ludwig ML: Free Radic Res Commun. 1991;25(Pt 1):259–268. 2071033.
Dobson AW, Erikson KM, Aschner M: Ann N Y Acad Sci. 2004;25: 115–128. 10.1196/annals.1306.009. 15105259.
Pal PK, Samii A, Calne DB: Neurotoxicology. 1999;25: 227–238. 10385886.
Aschner M, Shanker G, Erikson K, Yang J, Mutkus LA: Neurotoxicology. 2002;25: 165–168. 10.1016/S0161-813X(02)00056-6. 12224757.
Keen CL, Ensunsa JL, Watson MH, Baly DL, Donovan SM, Monaco MH, Clegg MS: Neurotoxicology. 1999;25: 213–223. 10385885.
Hurley LS: Physiol Rev. 1981;25: 249–295. 7012858.
Klimis-Tavantzis DJ, Leach RM, Kris-Etherton PM: J Nutr. 1983;25: 328–336. 6822906.
Burton NC, Guilarte TR: Environ Health Perspect. 2009;25: 325–332. 19337503.
Cooper WC: J Toxicol Environ Health. 1984;25: 23–46. 10.1080/15287398409530561. 6389893.
Bader M, Dietz MC, Ihrig A, Triebig G: Int Arch Occup Environ Health. 1999;25: 521–527. 10.1007/s004200050410. 10592004.
Bast-Pettersen R, Ellingsen DG, Hetland SM, Thomassen Y: Int Arch Occup Environ Health. 2004;25: 277–287. 10.1007/s00420-003-0491-0. 15024571.
Bowler RM, Nakagawa S, Drezgic M, Roels HA, Park RM, Diamond E, Mergler D, Bouchard M, Bowler RP, Koller W: Neurotoxicology. 2007;25: 298–311. 10.1016/j.neuro.2006.11.001. 17169432.
Montes S, Riojas-Rodriguez H, Sabido-Pedraza E, Rios C: Environ Res. 2008;25: 89–95. 10.1016/j.envres.2007.08.008. 17915211.
Srivastava AK, Gupta BN, Mathur N, Murty RC, Garg N, Chandra SV: Vet Hum Toxicol. 1991;25: 280–282. 1858313.
Finley JW, Davis CD: BioFactors (Oxford, England). 1999;25: 15–24. 10.1002/biof.5520100102.
ATSDR. Toxicological Profile for Manganese. 2000, Atlanta. GA: Agency for Toxic Substances and Disease Registry.
Krachler M, Rossipal E: Ann Nutr Metab. 2000;25: 68–74. 10.1159/000012823. 10970995.
Bertinet DB, Tinivella M, Balzola FA, de Francesco A, Davini O, Rizzo L, Massarenti P, Leonardi MA, Balzola F: JPEN. Journal of parenteral and enteral nutrition. 2000;25: 223–227. 10.1177/0148607100024004223. 10885716.
Hardy G: Gastroenterology. 2009;25: S29–S35. 10.1053/j.gastro.2009.08.011. 19874947.
Davis JM: Environ Health Perspect. 1998;25(Suppl 1):191–201. 10.1289/ehp.98106s1191. 9539013.
Kaiser J: Science (New York, N.Y.). 2003;25: 926–928. 10.1126/science.300.5621.926.
Sikk K, Taba P, Haldre S, Bergquist J, Nyholm D, Askmark H, Danfors T, Sorensen J, Thurfjell L, Raininko R, Eriksson R, Flink R, Farnstrand C, Aquilonius SM: Acta Neurol Scand. 2010;25: 237–243. 10.1111/j.1600-0404.2009.01189.x. 20028341.
Davidsson L, Cederblad A, Hagebo E, Lonnerdal B, Sandstrom B: J Nutr. 1998;25: 1517–1521.
Mena I: Ann Clin Lab Sci. 1974;25: 487–491. 4429343.
Davis CD, Zech L, Greger JL: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1993;25:103–108.Article
Dorman DC, Struve MF, James RA, McManus BE, Marshall MW, Wong BA: Toxicological sciences : an official journal of the Society of Toxicology. 2001;25: 242–251. 10.1093/toxsci/60.2.242. 11248135.
Davis CD, Malecki EA, Greger JL: Am J Clin Nutr. 1992;25: 926–932. 1415012.
Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA: Nature. 1997;25: 482–488. 10.1038/41343. 9242408.
Aisen P, Aasa R, Redfield AG: J Biol Chem. 1969;25: 4628–4633. 4309148.
Critchfield JW, Keen CL: Metabolism: clinical and experimental. 1992;25: 1087–1092. 10.1016/0026-0495(92)90290-Q. 1406294.
Aschner M, Gannon M: Brain Res Bull. 1994;25: 345–349. 10.1016/0361-9230(94)90204-6. 8293318.
Au C, Benedetto A, Aschner M: Neurotoxicology. 2008;25: 569–576. 10.1016/j.neuro.2008.04.022. 18565586.
Itoh K, Sakata M, Watanabe M, Aikawa Y, Fujii H: Neuroscience. 2008;25: 732–740. 10.1016/j.neuroscience.2008.03.080. 18495352.
Aschner M, Aschner JL: Brain Res Bull. 1990;25: 857–860. 10.1016/0361-9230(90)90152-P. 2372703.
Dorman DC, Struve MF, Marshall MW, Parkinson CU, James RA, Wong BA: Toxicological sciences : an official journal of the Society of Toxicology. 2006;25: 201–210. 10.1093/toxsci/kfj206. 16624849.
Guilarte TR, McGlothan JL, Degaonkar M, Chen MK, Barker PB, Syversen T, Schneider JS: Toxicological sciences : an official journal of the Society of Toxicology. 2006;25: 351–358. 10.1093/toxsci/kfl106. 16968886.
Erikson KM, Aschner M: Neurotoxicology. 2006;25: 125–130. 10.1016/j.neuro.2005.07.003. 16140386.
Suarez N, Eriksson H: J Neurochem. 1993;25: 127–131. 10.1111/j.1471-4159.1993.tb03546.x. 8515258.
Rehnberg GL, Hein JF, Carter SD, Laskey JW: J Toxicol Environ Health. 1980;25: 217–226. 10.1080/15287398009529844. 7381972.
Mena I, Marin O, Fuenzalida S, Cotzias GC: Neurology. 1967;25: 128–136. 10.1212/WNL.17.2.128. 6066873.
Roels HA, Bowler RM, Kim Y, Claus Henn B, Mergler D, Hoet P, Gocheva VV, Bellinger DC, Wright RO, Harris MG, Chang Y, Bouchard MF, Riojas-Rodriguez H, Menezes-Filho JA, Tellez-Rojo MM: Neurotoxicology. 2012;25: 872–880. 10.1016/j.neuro.2012.03.009. 22498092.
Mergler D, Huel G, Bowler R, Iregren A, Belanger S, Baldwin M, Tardif R, Smargiassi A, Martin L: Environ Res. 1994;25: 151–180. 10.1006/enrs.1994.1013. 8306949.
Couper J: Br Ann Med Pharmacol. 1837;25: 41–42.
Bowman AB, Kwakye GF, Hernandez EH, Aschner M: Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS). 2011;25: 191–203. 10.1016/j.jtemb.2011.08.144. 21963226.
Olanow CW: Ann N Y Acad Sci. 2004;25: 209–223. 10.1196/annals.1306.018. 15105268.
Calne DB, Chu NS, Huang CC, Lu CS, Olanow W: Neurology. 1994;25: 1583–1586. 10.1212/WNL.44.9.1583. 7936278.
Yamada M, Ohno S, Okayasu I, Okeda R, Hatakeyama S, Watanabe H, Ushio K, Tsukagoshi H: Acta Neuropathol. 1986;25: 273–278. 10.1007/BF00686083. 3766127.
Verina T, Schneider JS, Guilarte TR: Toxicol Lett. 2012.
Guilarte TR: Environ Health Perspect. 2010;25: 1071–80. 10.1289/ehp.0901748. 20403794.
Sikk K, Haldre S, Aquilonius SM, Taba P: Parkinson's disease. 2011;25: 865319. 23671637.
Li Y, Sun L, Cai T, Zhang Y, Lv S, Wang Y, Ye L: Brain Res Bull. 2010;25: 428–33. 10.1016/j.brainresbull.2009.11.007. 19932157.
Uversky VN, Li J, Fink AL: J Biol Chem. 2001;25: 44284–96. 10.1074/jbc.M105343200. 11553618.
Eller M, Williams DR: Clinical chemistry and laboratory medicine: CCLM / FESCC. 2011;25: 403–8. 21342025.
Gavin CE, Gunter KK, Gunter TE: Neurotoxicology. 1999;25: 445–53. 10385903.
Chen JY, Tsao GC, Zhao Q, Zheng W: Toxicol Appl Pharmacol. 2001;25: 160–8. 10.1006/taap.2001.9245. 11543648.
Gavin CE, Gunter KK, Gunter TE: Toxicol Appl Pharmacol. 1992;25: 1–5. 10.1016/0041-008X(92)90360-5. 1631887.
Milatovic D, Yin Z, Gupta RC, Sidoryk M, Albrecht J, Aschner JL, Aschner M: Toxicological sciences : an official journal of the Society of Toxicology. 2007;25: 198–205. 10.1093/toxsci/kfm095. 17468184.
Reaney SH, Smith DR: Toxicol Appl Pharmacol. 2005;25: 271–81. 10.1016/j.taap.2004.10.013. 15922012.
Yin Z, Aschner JL, dos Santos AP, Aschner M: Brain Res. 2008;25: 1–11. 18313649.
Zoratti M, Szabo I: Biochim Biophys Acta. 1995;25: 139–76. 10.1016/0304-4157(95)00003-A. 7640294.
Ramesh GT, Ghosh D, Gunasekar PG: Toxicol Lett. 2002;25: 151–8. 10.1016/S0378-4274(02)00332-6. 12425965.
Wise K, Manna S, Barr J, Gunasekar P, Ramesh G: Toxicol Lett. 2004;25: 237–44. 10.1016/j.toxlet.2003.11.007. 15104115.
Dauer W, Przedborski S: Neuron. 2003;25: 889–909. 10.1016/S0896-6273(03)00568-3. 12971891.
Latchoumycandane C, Anantharam V, Kitazawa M, Yang Y, Kanthasamy A, Kanthasamy AG: J Pharmacol Exp Ther. 2005;25: 46–55. 15608081.
Gonzalez LE, Juknat AA, Venosa AJ, Verrengia N, Kotler ML: Neurochem Int. 2008;25: 408–15. 10.1016/j.neuint.2008.09.008. 18930091.
Liu X, Sullivan KA, Madl JE, Legare M, Tjalkens RB: Toxicological sciences: an official journal of the Society of Toxicology. 2006;25: 521–31. 10.1093/toxsci/kfj150. 16551646.
Zhang P, Lokuta KM, Turner DE, Liu B: J Neurochem. 2010;25: 434–43. 10.1111/j.1471-4159.2009.06477.x. 19895668.
Zhang P, Wong TA, Lokuta KM, Turner DE, Vujisic K, Liu B: Exp Neurol. 2009;25: 219–30. 10.1016/j.expneurol.2009.02.013. 19268665.
Filipov NM, Dodd CA: Journal of applied toxicology: JAT. 2012;25: 310–7. 10.1002/jat.1762. 22120544.
Aschner M, Guilarte TR, Schneider JS, Zheng W: Toxicol Appl Pharmacol. 2007;25: 131–47. 10.1016/j.taap.2007.03.001. 17466353.
Chen MK, Lee JS, McGlothan JL, Furukawa E, Adams RJ, Alexander M, Wong DF, Guilarte TR: Neurotoxicology. 2006;25: 229–36. 10.1016/j.neuro.2005.10.008. 16325911.
Aschner M, Erikson KM, Herrero Hernandez E, Tjalkens R: Neuromolecular Med. 2009;25: 252–66. 10.1007/s12017-009-8083-0. 19657747.
Gorovits R, Avidan N, Avisar N, Shaked I, Vardimon L: Proc Natl Acad Sci USA. 1997;25: 7024–9. 10.1073/pnas.94.13.7024. 9192685.
Tholey G, Ledig M, Mandel P, Sargentini L, Frivold AH, Leroy M, Grippo AA, Wedler FC: Neurochem Res. 1988;25: 45–50. 10.1007/BF00971853. 2897087.
Brouillet EP, Shinobu L, McGarvey U, Hochberg F, Beal MF: Exp Neurol. 1993;25: 89–94. 10.1006/exnr.1993.1042. 8477830.
Desole MS, Sciola L, Delogu MR, Sircana S, Migheli R, Miele E: Neurochem Int. 1997;25: 169–76. 10.1016/S0197-0186(96)00146-5. 9220449.
Olanow CW, Good PF, Shinotoh H, Hewitt KA, Vingerhoets F, Snow BJ, Beal MF, Calne DB, Perl DP: Neurology. 1996;25: 492–8. 10.1212/WNL.46.2.492. 8614520.
Rama Rao KV, Reddy PV, Hazell AS, Norenberg MD: Neurotoxicology. 2007;25: 807–12. 10.1016/j.neuro.2007.03.001. 17408748.
Erikson K, Aschner M: Neurotoxicology. 2002;25: 595–602. 10.1016/S0161-813X(02)00012-8. 12428731.
Sidoryk-Wegrzynowicz M, Lee E, Albrecht J, Aschner M: J Neurochem. 2009;25: 822–30. 10.1111/j.1471-4159.2009.06172.x. 19457077.
Deng Y, Xu Z, Xu B, Xu D, Tian Y, Feng W: Biol Trace Elem Res. 2012;25: 242–9. 10.1007/s12011-012-9365-1. 22391793.
Lee ES, Sidoryk M, Jiang H, Yin Z, Aschner M: J Neurochem. 2009;25: 530–44. 10.1111/j.1471-4159.2009.06105.x. 19453300.
Lee ES, Yin Z, Milatovic D, Jiang H, Aschner M: Toxicological sciences: an official journal of the Society of Toxicology. 2009;25: 156–67. 10.1093/toxsci/kfp081. 19383943.
Sidoryk-Wegrzynowicz M, Lee ES, Ni M, Aschner M: Glia. 2010;25: 1905–12. 10.1002/glia.21060. 20737472.
Sitcheran R, Gupta P, Fisher PB, Baldwin AS: EMBO J. 2005;25: 510–20. 10.1038/sj.emboj.7600555. 15660126.
Sorg O, Horn TF, Yu N, Gruol DL, Bloom FE: Molecular medicine (Cambridge, Mass.). 1997;25: 431–40.
Su ZZ, Leszczyniecka M, Kang DC, Sarkar D, Chao W, Volsky DJ, Fisher PB: Proc Natl Acad Sci USA. 2003;25: 1955–60. 10.1073/pnas.0136555100. 12578975.
Trotti D, Danbolt NC, Volterra A: Trends Pharmacol Sci. 1998;25: 328–34. 10.1016/S0165-6147(98)01230-9. 9745361.
Miralles VJ, Martinez-Lopez I, Zaragoza R, Borras E, Garcia C, Pallardo FV, Vina JR: Brain Res. 2001;25: 21–9. 10.1016/S0006-8993(01)03124-9. 11730698.
Crittenden PL, Filipov NM: Toxicology in vitro : an international journal published in association with BIBRA. 2008;25: 18–27. 10.1016/j.tiv.2007.07.004. 17845838.

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Sex-specific associations of a ferroalloy metal mixture with motor function in Italian adolescents
Alexa Friedman, Samantha Schildroth, Victoria Fruh, Maxine H. Krengel, Yorghos Tripodis, Donatella Placidi, Roberta F. White, Roberto G. Lucchini, Donald R. Smith, Robert O. Wright, Megan K. Horton, Birgit Claus Henn
Environmental Epidemiology.2024; 8(4): e321. CrossRef
Astrocyte dysregulation as an epileptogenic factor: a systematic review
Komang Trisna Sumadewi, Bryan Gervais de Liyis, Ni Made Linawati, I Putu Eka Widyadharma, I Nyoman Mantik Astawa
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.2024;[Epub] CrossRef
Lactational Exposure of Human Infants to Metal (loid)s: A Comparison of Industrial and Urban Inhabitants in North of the Persian Gulf
Leila Amiri, Atefeh Khalili Doroodzani, Afshin Ostovar, Sina Dobaradaran, Azam Mohammadi, Iraj Nabipour, Alireza Raeisi, Hasan Malekizadeh, Akram Farhadi, Reza Saeedi, Sima Afrashteh, Shahrokh Nazmara, Mozhgan Keshtkar
Biological Trace Element Research.2024; 202(5): 1829. CrossRef
Pathogenesis and management of multiple sclerosis revisited
Abhi Shah, Viraj Panchal, Kashyap Patel, Zainab Alimohamed, Nirja Kaka, Yashendra Sethi, Neil Patel
Disease-a-Month.2023; 69(9): 101497. CrossRef
Structures and coordination chemistry of transporters involved in manganese and iron homeostasis
Shamayeeta Ray, Rachelle Gaudet
Biochemical Society Transactions.2023; 51(3): 897. CrossRef
The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders
Sahar Alijanpour, Mohammad Miryounesi, Soudeh Ghafouri-Fard
Metabolic Brain Disease.2023; 38(1): 1. CrossRef
Transcranial direct current stimulation ameliorates motor and cognitive functions by regulating neuronal excitotoxicity in experimental Parkinson’s disease model
Güven AKÇAY, Serhan TAMERER
Cukurova Medical Journal.2023; 48(3): 919. CrossRef
Effects of Chronic Hydrocodone Exposure and Ceftriaxone on the Expression of Astrocytic Glutamate Transporters in Mesocorticolimbic Brain Regions of C57/BL Mice
Woonyen Wong, Youssef Sari
Toxics.2023; 11(10): 870. CrossRef
Upregulation of glutamate transporter 1 by mTOR/Akt pathway in astrocyte culture during oxygen–glucose deprivation and reoxygenation
Mi Li, Jingmei Yu, Huan Deng, Shansha Xie, Qiuling Li, Yuping Zhao, Shubin Yin, Yi-Fei Ji
Experimental Brain Research.2023; 241(1): 201. CrossRef
Munc18-1 Contributes to Hippocampal Injury in Septic Rats Through Regulation of Syntanxin1A and Synaptophysin and Glutamate Levels
Fajuan Tang, Lin Chen, Hu Gao, Yupeng Lei, Linli Pan, Dongqiong Xiao, Xihong Li
Neurochemical Research.2023; 48(3): 791. CrossRef
Comparative analysis of astrocytes in the prefrontal cortex of primates: Insights into the evolution of human brain energetics
Emily L. Munger, Melissa K. Edler, William D. Hopkins, Patrick R. Hof, Chet C. Sherwood, Mary Ann Raghanti
Journal of Comparative Neurology.2022; 530(18): 3106. CrossRef
Ultrasmall Fe@Fe3O4 nanoparticles as T1–T2 dual-mode MRI contrast agents for targeted tumor imaging
Donglin Liu, Jiaojiao Li, Chengbin Wang, Lu An, Jiaomin Lin, Qiwei Tian, Shiping Yang
Nanomedicine: Nanotechnology, Biology and Medicine.2021; 32: 102335. CrossRef
Effects of Pentoxifylline in a Rat Model of Manganism: Evaluation of the Possible Toxicity
Romina Tanideh, Omid Farshad, Akram Jamshidzadeh, Aida Iraji, Murat Senturk
Journal of Chemistry.2021; 2021: 1. CrossRef
Exercise increases striatal Glu reuptake and improves motor dysfunction in 6-OHDA-induced Parkinson’s disease rats
Yan Feng, Shifang Zhou, Jian Sun
Experimental Brain Research.2021; 239(11): 3277. CrossRef
Single step nanospray drying preparation technique of gabapentin-loaded nanoparticles-mediated brain delivery for effective treatment of PTZ-induced seizures
Alaa H. Salama, Abeer A.A. Salama, Mona Elhabak
International Journal of Pharmaceutics.2021; 602: 120604. CrossRef
Micellar buccal film for safe and effective control of seizures: Preparation, in vitro characterization, ex vivo permeation studies and in vivo assessment
Alaa H. Salama, Mona Basha, Abeer A.A. Salama
European Journal of Pharmaceutical Sciences.2021; 166: 105978. CrossRef
Magnetic Nanoparticles in Cancer Therapy and Diagnosis
Ali Farzin, Seyed Alireza Etesami, Jacob Quint, Adnan Memic, Ali Tamayol
Advanced Healthcare Materials.2020;[Epub] CrossRef
Associations between manganese exposure and multiple immunological parameters in manganese-exposed workers healthy cohort
Xiang Chen, Zhenfang Liu, Xiaoting Ge, Xiaoyu Luo, Sifang Huang, Yanting Zhou, Defu Li, Hong Cheng, Longman Li, Lulu Huang, Qingzhi Hou, Gaohui Zan, Yanli Tan, Chaoqun Liu, Yunfeng Zou, Xiaobo Yang
Journal of Trace Elements in Medicine and Biology.2020; 59: 126454. CrossRef
Glutamate Transporters (EAAT-1–3) as a Factor in the Pathogenesis and a Potential Therapeutic Target in Epilepsy
I. V. Smolensky, S. V. Ovsepian, A. V. Zaitsev
Neuroscience and Behavioral Physiology.2020; 50(6): 777. CrossRef
Sodium Para-aminosalicylic Acid Reverses Changes of Glutamate Turnover in Manganese-Exposed Rats
Zhao-Cong Li, Fang Wang, Shao-Jun Li, Lin Zhao, Jun-Yan Li, Yue Deng, Xiao-Juan Zhu, Yu-Wen Zhang, Dong-Jie Peng, Yue-Ming Jiang
Biological Trace Element Research.2020; 197(2): 544. CrossRef
6-OHDA ile Oluşturulan Parkinson Hastalığı Modelinde Astrogliozis ve Glutamat Taşıyıcı Protein GLT1 Ekspresyonu
Zehra MİNBAY, Bülent GÖREN, Özhan EYİGÖR
Uludağ Üniversitesi Tıp Fakültesi Dergisi.2020; 46(3): 385. CrossRef
Dysregulation of TFEB contributes to manganese-induced autophagic failure and mitochondrial dysfunction in astrocytes
Ziyan Zhang, Jingqi Yan, Aaron B. Bowman, Miles R. Bryan, Rajat Singh, Michael Aschner
Autophagy.2020; 16(8): 1506. CrossRef
Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy
Aleksey V. Zaitsev, Ilya V. Smolensky, Pascal Jorratt, Saak V. Ovsepian
CNS Drugs.2020; 34(11): 1089. CrossRef
Dietary Intake and Urinary Excretion of Manganese in Korean Healthy Adults
Mi-Kyeong Choi, Yun Jung Bae
Biological Trace Element Research.2020; 196(2): 384. CrossRef
Ceftriaxone Treatment Affects EAAT2 Expression and Glutamatergic Neurotransmission and Exerts a Weak Anticonvulsant Effect in Young Rats
Aleksey V. Zaitsev, Sergey L. Malkin, Tatyana Y. Postnikova, Ilya V. Smolensky, Olga E. Zubareva, Irina V. Romanova, Maria V. Zakharova, Vladimir B. Karyakin, Vladimir Zavyalov
International Journal of Molecular Sciences.2019; 20(23): 5852. CrossRef
Brain mitochondria as potential therapeutic targets for managing hepatic encephalopathy
Reza Heidari
Life Sciences.2019; 218: 65. CrossRef
Role of Astrocytes in Manganese Neurotoxicity Revisited
Tao Ke, Marta Sidoryk-Wegrzynowicz, Edward Pajarillo, Asha Rizor, Félix Alexandre Antunes Soares, Eunsook Lee, Michael Aschner
Neurochemical Research.2019; 44(11): 2449. CrossRef
The role of zinc, copper, manganese and iron in neurodegenerative diseases
Leda Mezzaroba, Daniela Frizon Alfieri, Andrea Name Colado Simão, Edna Maria Vissoci Reiche
NeuroToxicology.2019; 74: 230. CrossRef
The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics
Edward Pajarillo, Asha Rizor, Jayden Lee, Michael Aschner, Eunsook Lee
Neuropharmacology.2019; 161: 107559. CrossRef
Association of circulating manganese levels with Parkinson’s disease: A meta-analysis
Ke Du, Ming-Yan Liu, Yan-Zhu Pan, Xin Zhong, Min-Jie Wei
Neuroscience Letters.2018; 665: 92. CrossRef
Synthesis and characterization of [Mn(phen)(H 2 O) 4 ]·SO 4 ·2H 2 O
Ibanphylla Syiemlieh, Arvind Kumar, Sunshine D. Kurbah, Ram A. Lal
Journal of Molecular Structure.2018; 1166: 102. CrossRef
Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes
Souvarish Sarkar, Emir Malovic, Dilshan S. Harischandra, Hilary A. Ngwa, Anamitra Ghosh, Colleen Hogan, Dharmin Rokad, Gary Zenitsky, Huajun Jin, Vellareddy Anantharam, Anumantha G. Kanthasamy, Arthi Kanthasamy
NeuroToxicology.2018; 64: 204. CrossRef
The Impact of Environmental Mn Exposure on Insect Biology
Yehuda Ben-Shahar
Frontiers in Genetics.2018;[Epub] CrossRef
Assessment of gender and age effects on serum and hair trace element levels in children with autism spectrum disorder
Anatoly V. Skalny, Natalia V. Simashkova, Anastasia A. Skalnaya, Tatiana P. Klyushnik, Geir Bjørklund, Margarita G. Skalnaya, Alexey A. Tinkov
Metabolic Brain Disease.2017; 32(5): 1675. CrossRef
Cellular Fates of Manganese(II) Pentaazamacrocyclic Superoxide Dismutase (SOD) Mimetics: Fluorescently Labeled MnSOD Mimetics, X-ray Absorption Spectroscopy, and X-ray Fluorescence Microscopy Studies
Claire M. Weekley, Isabell Kenkel, Rainer Lippert, Shengwei Wei, Dominik Lieb, Tiffanny Cranwell, Jason L. Wedding, Annika S. Zillmann, Robin Rohr, Milos R. Filipovic, Ivana Ivanović-Burmazović, Hugh H. Harris
Inorganic Chemistry.2017; 56(11): 6076. CrossRef
Health status of male steel workers at an electric arc furnace (EAF) in Trentino, Italy
Roberto Cappelletti, Marcello Ceppi, Justina Claudatus, Valerio Gennaro
Journal of Occupational Medicine and Toxicology.2016;[Epub] CrossRef
Biochemical and ecophysiological responses to manganese stress by ectomycorrhizal fungus Pisolithus tinctorius and in association with Eucalyptus grandis
Gabriela C. Canton, Amanda A. Bertolazi, Antônio J. D. Cogo, Frederico Jacob Eutrópio, Juliana Melo, Sávio Bastos de Souza, Cesar A. Krohling, Eliemar Campostrini, Ary Gomes da Silva, Arnoldo R. Façanha, Nuno Sepúlveda, Cristina Cruz, Alessandro C. Ramos
Mycorrhiza.2016; 26(5): 475. CrossRef
Null allele mutants of trt-1 , the catalytic subunit of telomerase in Caenorhabditis elegans , are less sensitive to Mn-induced toxicity and DAergic degeneration
Omamuyovwi M. Ijomone, Mahfuzur R. Miah, Tanara V. Peres, Polycarp U. Nwoha, Michael Aschner
NeuroToxicology.2016; 57: 54. CrossRef
Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy
Nohyun Lee, Dongwon Yoo, Daishun Ling, Mi Hyeon Cho, Taeghwan Hyeon, Jinwoo Cheon
Chemical Reviews.2015; 115(19): 10637. CrossRef
Changes in Brain Metallome/Metabolome Pattern due to a Single i.v. Injection of Manganese in Rats
Katharina Neth, Marianna Lucio, Alesia Walker, Julia Zorn, Philippe Schmitt-Kopplin, Bernhard Michalke, Fanis Missirlis
PLOS ONE.2015; 10(9): e0138270. CrossRef
Manganese-induced neurotoxicity: from C. elegans to humans
Pan Chen, Sudipta Chakraborty, Tanara V. Peres, Aaron B. Bowman, Michael Aschner
Toxicology Research.2015; 4(2): 191. CrossRef
Complex liaisons moving forward the Parkinson’s disease? An appraisal
Graziella Rubino
Basal Ganglia.2015; 5(4): 77. CrossRef
α-Synuclein Protects Against Manganese Neurotoxic Insult During the Early Stages of Exposure in a Dopaminergic Cell Model of Parkinson’s Disease
Dilshan S. Harischandra, Huajun Jin, Vellareddy Anantharam, Arthi Kanthasamy, Anumantha G. Kanthasamy
Toxicological Sciences.2015; 143(2): 454. CrossRef
Effects of developmental exposure to manganese and/or low iron diet: Changes to metal transporters, sucrose preference, elevated zero-maze, open-field, and locomotion in response to fenfluramine, amphetamine, and MK-801
Robyn M. Amos-Kroohs, Colin P. Bloor, Momina A. Qureshi, Charles V. Vorhees, Michael T. Williams
Toxicology Reports.2015; 2: 1046. CrossRef
Is it possible to enhance the organism’s resistance to toxic effects of metallic nanoparticles?
Boris A. Katsnelson, Larisa I. Privalova, Marina P. Sutunkova, Ilzira A. Minigalieva, Vladimir B. Gurvich, Vladimir Y. Shur, Oleg H. Makeyev, Irina E. Valamina, Ekaterina V. Grigoryeva
Toxicology.2015; 337: 79. CrossRef
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
Peter Surai
Antioxidants.2015; 4(1): 204. CrossRef
Attenuation of Combined Nickel(II) Oxide and Manganese(II, III) Oxide Nanoparticles’ Adverse Effects with a Complex of Bioprotectors
Ilzira Minigalieva, Boris Katsnelson, Larisa Privalova, Marina Sutunkova, Vladimir Gurvich, Vladimir Shur, Ekaterina Shishkina, Irene Valamina, Oleg Makeyev, Vladimir Panov, Anatoly Varaksin, Ekaterina Grigoryeva, Ekaterina Meshtcheryakova
International Journal of Molecular Sciences.2015; 16(9): 22555. CrossRef
Blood Metal Concentrations of Manganese, Lead, and Cadmium in Relation to Serum Ferritin Levels in Ohio Residents
Yangho Kim, Danelle T. Lobdell, Chris W. Wright, Vihra V. Gocheva, Edward Hudgens, Rosemarie M. Bowler
Biological Trace Element Research.2015; 165(1): 1. CrossRef
Neutron Activation Analysis of Scalp Hair from ALS Patients and Residents in the Kii Peninsula, Japan
Tameko Kihira, Iori Sakurai, Sohei Yoshida, Ikuro Wakayama, Koichi Takamiya, Ryo Okumura, Yuhto Iinuma, Keiko Iwai, Yoshinori Kajimoto, Yasuhiro Hiwatani, Junko Kohmoto, Kazushi Okamoto, Yasumasa Kokubo, Shigeki Kuzuhara
Biological Trace Element Research.2015; 164(1): 36. CrossRef
Correlation between the biochemical pathways altered by mutated parkinson-related genes and chronic exposure to manganese
Jerome A. Roth
NeuroToxicology.2014; 44: 314. CrossRef
Iron Deficiency is Not Associated with Increased Blood Cadmium in Infants
Jung-Hun Park, Sangkyu Park, Yangho Kim
Annals of Occupational and Environmental Medicine.2014;[Epub] CrossRef
Manganese leads to an increase in markers of oxidative stress as well as to a shift in the ratio of Fe(ii)/(iii) in rat brain tissue
Katharina Fernsebner, Julia Zorn, Basem Kanawati, Alesia Walker, Bernhard Michalke
Metallomics.2014; 6(4): 921. CrossRef
Iron deficiency increases blood concentrations of neurotoxic metals in children
Yangho Kim, Sangkyu Park
Korean Journal of Pediatrics.2014; 57(8): 345. CrossRef
Sex-specific Profiles of Blood Metal Levels Associated with Metal–Iron Interactions
Byung-Kook Lee, Yangho Kim
Safety and Health at Work.2014; 5(3): 113. CrossRef
Blood Manganese Concentration is Elevated in Infants with Iron Deficiency
Sangkyu Park, Chang-Sun Sim, Heun Lee, Yangho Kim
Biological Trace Element Research.2013; 155(2): 184. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Manganese Neurotoxicity: a Focus on Glutamate Transporters

Ann Occup Environ Med. 2013;25:4-4. Published online May 21, 2013

DOI: https://doi.org/10.1186/2052-4374-25-4

XML Download

Manganese Neurotoxicity: a Focus on Glutamate Transporters